Goldman Sachs Group »

Dyne Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 1.2M 13.30
2023-09-30 $14M 1.5M 8.96
2023-06-30 $23M 2.0M 11.25
2023-03-31 $17M 1.5M 11.52
2022-12-31 $9.7M 836k 11.59
2022-06-30 $454k 66k 6.88
2022-03-31 $757k 79k 9.63
2021-12-31 $1.0M 85k 11.88
2021-09-30 $637k 39k 16.23
2021-03-31 $1.6M 103k 15.53
2020-12-31 $939k 45k 21.00
2020-09-30 $3.6M 178k 20.19